DAWN

Finance

Day One Biopharmaceuticals Inc [DAWN] Revenue clocked in at $133.67 million, down -44.20% YTD: What’s Next?

Caleb Clifford

Day One Biopharmaceuticals Inc [NASDAQ: DAWN] slipped around -1.49 points on Thursday, while shares priced at $8.85 at the close ...

Industry

Piper Sandler slashes price target on Day One Biopharmaceuticals Inc [DAWN] – find out why.

Caleb Clifford

Day One Biopharmaceuticals Inc [NASDAQ: DAWN] closed the trading session at $9.14 on 2025-11-05. The day’s price range saw the ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.